Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000298118 is an annotated antisense transcript relative to the NT5C3A gene. There is no evidence that it encodes a protein, nor is it listed as an established therapeutic target, receptor, enzyme, or regulatory molecule in curated databases. There is also no association with drugs, mechanisms of action, or relevant disease roles. This entry is likely present as a result of genome annotation efforts to catalog all transcribed regions, including non-coding RNAs and antisense transcripts. There is no indication of biological function or clinical utility from available data[5]. This should not be confused with NT5C3A (Cytosolic 5'-nucleotidase 3A), which is a protein-coding gene and a true enzyme with known functions and disease associations[1][3]. The antisense transcript likely represents a genomic feature with unclear or no functional significance. "novel transcript" terminology suggests insufficient characterization and lack of protein product, and antisense transcripts are often annotated through high-throughput sequencing projects with unclear biological roles. In summary, "novel transcript, antisense to NT5C3A" (ENSG00000298118) is not a conventional molecular target (not a receptor, enzyme, transporter, etc.), its clinical or biological relevance is unestablished, and it is likely not suitable for use in drug discovery or mechanistic research[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to NT5C3A.